Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Net Cash Flow (2024 - 2025)

Historic Net Cash Flow for Beta Bionics (BBNX) over the last 2 years, with Q3 2025 value amounting to $3.4 million.

  • Beta Bionics' Net Cash Flow fell 2342.24% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 33119.43%. This contributed to the annual value of $3.9 million for FY2024, which is 44860.23% up from last year.
  • Beta Bionics' Net Cash Flow amounted to $3.4 million in Q3 2025, which was down 2342.24% from -$7.4 million recorded in Q2 2025.
  • Beta Bionics' 5-year Net Cash Flow high stood at $13.0 million for Q4 2024, and its period low was -$9.0 million during Q2 2024.